Apellis Pharmaceuticals, Inc. (APLS)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 18, 16:00
Apellis Pharmaceuticals EPS Diluted (TTM) : 1.001 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 9.318 |
| Eli Lilly & Co. | 27.78 |
| Agios Pharmaceuticals, Inc. | -7.251 |
| Spyre Therapeutics, Inc. | -2.358 |
| Scholar Rock Holding Corp. | -3.586 |